Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $842.59 | 50 | 95.5% |
| Education | $39.34 | 2 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $148.68 | 9 | $0 (2019) |
| Amgen Inc. | $106.57 | 6 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $78.37 | 5 | $0 (2017) |
| Fresenius USA Marketing, Inc. | $65.59 | 4 | $0 (2018) |
| BAXTER HEALTHCARE | $50.73 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $49.76 | 3 | $0 (2019) |
| GENZYME CORPORATION | $41.22 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $35.30 | 2 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $34.50 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $30.67 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.83 | 2 | AKEBIA THERAPEUTICS INC ($24.61) |
| 2022 | $51.87 | 3 | Amgen Inc. ($19.25) |
| 2021 | $110.09 | 6 | Alexion Pharmaceuticals, Inc. ($20.49) |
| 2020 | $19.97 | 1 | Lundbeck LLC ($19.97) |
| 2019 | $174.44 | 11 | Otsuka America Pharmaceutical, Inc. ($66.16) |
| 2018 | $146.05 | 9 | Otsuka America Pharmaceutical, Inc. ($32.21) |
| 2017 | $334.68 | 20 | Keryx Biopharmaceuticals, Inc. ($78.37) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Neuromodulation | ||||||
| 12/05/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/14/2022 | Vifor Pharma, Inc. | Veltassa (Drug), Korsuva | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Hyperkalemia | ||||||
| 05/19/2022 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Nephrology | ||||||
| 02/02/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Nephrology | ||||||
| 08/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/18/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: NEPHROLOGY | ||||||
| 04/27/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Immunology | ||||||
| 02/18/2020 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: NEPHROLOGY | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEPHROLOGY | ||||||
| 08/13/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: KRYSTEXXA | ||||||
| 07/16/2019 | GENZYME CORPORATION | FABRY-DISEASE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| 07/03/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEPHROLOGY | ||||||
| 04/30/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2019 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEPHROLOGY | ||||||
| 02/05/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.89 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Nephrology | ||||||
| 11/13/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 664 | 1,300 | $454,990 | $148,446 |
| 2022 | 13 | 850 | 1,671 | $568,550 | $194,341 |
| 2021 | 13 | 997 | 2,159 | $720,140 | $241,937 |
| 2020 | 13 | 1,201 | 3,060 | $1.1M | $316,980 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 142 | 250 | $187,500 | $68,306 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 138 | 447 | $82,695 | $26,249 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 258 | $33,540 | $14,917 | 44.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 30 | 59 | $44,250 | $13,188 | 29.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 64 | 176 | $48,400 | $9,237 | 19.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 33 | $24,750 | $7,678 | 31.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $14,620 | $4,284 | 29.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 15 | 18 | $13,500 | $2,879 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,460 | $1,664 | 30.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 11 | 11 | $275.00 | $43.34 | 15.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 145 | 350 | $262,500 | $99,297 | 37.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 162 | 524 | $96,940 | $28,835 | 29.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 41 | 70 | $52,500 | $15,439 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 196 | 243 | $31,590 | $14,389 | 45.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 36 | 43 | $32,250 | $10,131 | 31.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 80 | 131 | $36,025 | $7,337 | 20.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 49 | $21,070 | $7,049 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $15,990 | $4,592 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 40 | $7,400 | $3,569 | 48.2% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 14 | 35 | $7,700 | $2,365 | 30.7% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 11 | 102 | $2,550 | $775.31 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 14 | 16 | $1,360 | $456.21 | 33.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 26 | 27 | $675.00 | $107.10 | 15.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 217 | 455 | $341,250 | $122,153 | 35.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 191 | 726 | $134,310 | $40,454 | 30.1% |
About Dr. John Shepherd, MD
Dr. John Shepherd, MD is a Nephrology healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1225031271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shepherd, MD has received a total of $881.93 in payments from pharmaceutical and medical device companies, with $44.83 received in 2024. These payments were reported across 52 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($842.59).
As a Medicare-enrolled provider, Shepherd has provided services to 3,712 Medicare beneficiaries, totaling 8,190 services with total Medicare billing of $901,704. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Pinehurst, NC
- Active Since 05/23/2005
- Last Updated 12/01/2009
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1225031271
Products in Payments
- SAMSCA (Drug) $115.88
- Auryxia (Drug) $78.37
- Parsabiv (Biological) $71.22
- LOKELMA (Drug) $49.76
- Velphoro (Drug) $49.05
- FABRY-DISEASE (Drug) $41.22
- Veltassa (Drug) $36.38
- Parsabiv (Drug) $35.35
- BENLYSTA (Biological) $35.30
- JYNARQUE (Drug) $32.80
- RENVELA (Drug) $30.67
- Renal - PD (Device) $28.27
- Vafseo (Drug) $24.61
- Renal - Acute (Device) $22.46
- Ultomiris (Drug) $20.49
- ETERNA (Device) $20.22
- NORTHERA (Drug) $19.97
- RAYALDEE (Drug) $19.95
- GATTEX (Drug) $18.39
- NATPARA (Drug) $18.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Pinehurst
Dr. Jennifer Stoddard, Md, MD
Nephrology — Payments: $61,585
Dr. Edward Hoehn-Saric, Md, MD
Nephrology — Payments: $3,104
Stephen Lombardi
Nephrology — Payments: $1,663
Dr. Hanna Von Hardenberg, Md, MD
Nephrology — Payments: $1,411
Gaylord Hoffert, Md, MD
Nephrology — Payments: $1,342